We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+1.66%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$40.3B
AUM Growth
-$672M
(-1.6%)
Cap. Flow
-$694M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
14.49%
Holding
2,585
New
23
Increased
499
Reduced
843
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$297M |
| 2 |
Tapestry
TPR
|
+$225M |
| 3 |
SLB Ltd
SLB
|
+$167M |
| 4 |
Qualcomm
QCOM
|
+$165M |
| 5 |
Applied Materials
AMAT
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$197M |
| 2 |
Nike
NKE
|
+$187M |
| 3 |
JAH
JARDEN CORPORATION
JAH
|
+$185M |
| 4 |
Intel
INTC
|
+$177M |
| 5 |
Cognizant
CTSH
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.25% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIAB
301
DELISTED
Viacom Inc. Class B
VIAB
| $23M | 0.06% |
556,724
-69,977
| -11% | -$2.78M |
|
302
Morgan Stanley
MS
$338B
| $22.9M | 0.06% |
916,785
+68,330
| +8% | +$1.74M |
|
303
Webster Financial
WBS
$12.8B
| $22.9M | 0.06% |
636,745
-3,890
| -0.6% | -$133K |
|
|
ABCO
304
DELISTED
Advisory Board Co
ABCO
| $22.8M | 0.06% |
706,894
+221,925
| +46% | +$8.29M |
|
305
Emerson Electric
EMR
$88.5B
| $22.7M | 0.06% |
417,704
-19,374
| -4% | -$934K |
|
306
Aptiv
APTV
$10.3B
| $22.4M | 0.06% |
299,001
-1,019,428
| -77% | -$69.8M |
|
|
NATI
307
DELISTED
National Instruments Corp
NATI
| $22.4M | 0.06% |
743,992
+9,902
| +1% | +$284K |
|
308
Guidewire Software
GWRE
$14.4B
| $22.4M | 0.06% |
410,619
+20,000
| +5% | +$1.04M |
|
309
General Mills
GIS
$19.9B
| $22.4M | 0.06% |
353,072
+118,871
| +51% | +$6.91M |
|
|
TWC
310
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $22.4M | 0.06% |
109,238
-1,798
| -2% | -$340K |
|
311
Enpro
NPO
$7.04B
| $22.3M | 0.06% |
387,213
-27,392
| -7% | -$1.32M |
|
312
Capital One
COF
$134B
| $22.2M | 0.06% |
321,004
-2,300
| -0.7% | -$152K |
|
313
Neurocrine Biosciences
NBIX
$16.8B
| $22.1M | 0.05% |
559,530
+24,300
| +5% | +$964K |
|
314
Lindsay Corp
LNN
$1.17B
| $22.1M | 0.05% |
308,818
+20,019
| +7% | +$1.44M |
|
|
TBI
315
Trueblue
TBI
$323M
| $22M | 0.05% |
840,423
+142,615
| +20% | +$3.3M |
|
316
Helen of Troy
HELE
$680M
| $21.8M | 0.05% |
210,695
+4,520
| +2% | +$422K |
|
|
VGR
317
DELISTED
Vector Group Ltd.
VGR
| $21.6M | 0.05% |
1,619,207
+162,860
| +11% | +$2.17M |
|
|
TLMR
318
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $21.4M | 0.05% |
1,180,827
+275,790
| +30% | +$4.66M |
|
319
Power Integrations
POWI
$3.46B
| $21.4M | 0.05% |
860,072
+11,250
| +1% | +$259K |
|
320
Boise Cascade
BCC
$2.96B
| $21.3M | 0.05% |
1,026,348
+239,506
| +30% | +$4.51M |
|
|
PVTB
321
DELISTED
PrivateBancorp Inc
PVTB
| $21.3M | 0.05% |
550,861
+40,828
| +8% | +$1.5M |
|
|
JNS
322
DELISTED
Janus Capital Group Inc
JNS
| $21.2M | 0.05% |
1,452,190
+51,805
| +4% | +$674K |
|
|
CYNO
323
DELISTED
Cynosure, Inc. Class A
CYNO
| $21.2M | 0.05% |
480,194
+5,990
| +1% | +$235K |
|
324
Bright Horizons
BFAM
$3.81B
| $21.1M | 0.05% |
326,198
+22,350
| +7% | +$1.44M |
|
325
Thermo Fisher Scientific
TMO
$222B
| $21.1M | 0.05% |
149,172
-3,603
| -2% | -$483K |
|
Similar funds
VOYA Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, VOYA Investment Management held 2,585 positions worth $40.3B, down 1.6% from $41B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2016: portfolio turnover was 3.7%. VOYA Investment Management opened 23 new positions and exited 72, leaving the 2,585-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- VOYA Investment Management's largest Q1 2016 buy was AstraZeneca: 495,025 shares worth $27.9M.
- VOYA Investment Management added most to AbbVie in Q1 2016, an estimated $297M increase.
- VOYA Investment Management's biggest Q1 2016 reduction was Pfizer, cutting an estimated $197M.
- VOYA Investment Management fully exited Blackstone in Q1 2016, selling an estimated $61.8M.
- VOYA Investment Management's ten largest holdings make up 14% of its $40.3B portfolio in Q1 2016.
- VOYA Investment Management opened 23 new positions and closed 72 in Q1 2016.
- VOYA Investment Management's portfolio value fell 1.6% quarter-over-quarter to $40.3B.
Based on VOYA Investment Management's 13F filing for Q1 2016, filed 16 May 2016.